Biote (BTMD) Non-Current Deffered Revenue (2020 - 2026)

Biote (BTMD) has reported Non-Current Deffered Revenue for 7 consecutive years, with $922000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Non-Current Deffered Revenue fell 36.41% year-over-year to $922000.0; the TTM figure through Mar 2026 stood at $922000.0 (down 36.41% YoY), while the FY2025 annual figure was $1.1 million, down 29.36% from the prior year.
• Non-Current Deffered Revenue came in at $922000.0 for Q1 2026 at Biote, down from $1.1 million in the prior quarter.
• The five-year high for Non-Current Deffered Revenue was $11.1 million in Q1 2022, with the low at $853000.0 in Q2 2022.
• Average Non-Current Deffered Revenue over 5 years is $1.8 million, with a median of $1.2 million recorded in 2025.
• Across the five-year window, Non-Current Deffered Revenue tumbled 92.32% in 2022 and jumped 44.16% in 2024, its largest moves.
• Year by year, Non-Current Deffered Revenue stood at $926000.0 in 2022, then soared by 42.76% to $1.3 million in 2023, then advanced by 17.47% to $1.6 million in 2024, then retreated by 29.36% to $1.1 million in 2025, then retreated by 15.95% to $922000.0 in 2026.
• According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $922000.0, $1.1 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.